Life sciences company focused on developing proprietary drugs to treat or prevent cardiovascular diseases. Current efforts are focused on the treatment of atrial arrhythmias and congestive heart failure.
The best Bull and Bear pitches based on recency and number of recommendations.
Just following some other highly ranked players. Didn't do any other due diligence.
Cardiome should be given credit for wriggling out of their heavy debt to Merck by paying only 40% of what they owed, but now they have to face a very uncertain future with only 28M in cash and a single asset that no one seems to want. When I saw that… More
Read the most recent pitches from players about CORV.DL.
Find the members with the highest scoring picks in CORV.DL.
See what the Wall Street professionals think, according to their public statements and filings.